OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease
Yunxia Luo, Dongli Li, Yanfang Liao, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice
Yanan Jiao, Jingsheng Zhang, Qiao Wen-jun, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 5, pp. 3294-3309
Open Access | Times Cited: 27

Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer’s disease through SIRT3/NLRP3 pathway
Shijie Su, Gongcan Chen, Minghuang Gao, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 13

Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice
Yu-Min Xu, Fang-Mei Lu, Hong-Cai Xu, et al.
Rejuvenation Research (2023) Vol. 26, Iss. 3, pp. 105-115
Closed Access | Times Cited: 12

New insights into effects of Kaixin Powder on depression via lipid metabolism related adiponectin signaling pathway
Wenshan Yang, Hong Yin, Yichen Wang, et al.
Chinese Herbal Medicines (2023) Vol. 15, Iss. 2, pp. 240-250
Open Access | Times Cited: 11

Progress of Kai-Xin-San in treating AD and depression: The possibility of "Homotherapy for Heteropathy"
Chang Liu, Jingji Wang, Guoqi Zhu
Pharmacological Research - Modern Chinese Medicine (2025), pp. 100589-100589
Open Access

Classic Famous Prescription Kai-Xin-San Ameliorates Alzheimer’s Disease via the Wnt/β-Catenin Signaling Pathway
Xiaoxiao Shan, Shujie Lv, Peng Huang, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 4, pp. 2297-2312
Closed Access | Times Cited: 10

Kai-Xin-San Attenuates Doxorubicin-Induced Cognitive Impairment by Reducing Inflammation, Oxidative Stress, and Neural Degeneration in 4T1 Breast Cancer Mice
Wenjiao Lyu, Mingzi Ouyang, Xiaomeng Ma, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-15
Open Access | Times Cited: 22

Systems pharmacology-based approach to investigate the mechanisms of Danggui-Shaoyao-san prescription for treatment of Alzheimer’s disease
Qihui Wu, Yunbo Chen, Yong Gu, et al.
BMC Complementary Medicine and Therapies (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 23

Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking
Yaling Hu, Shuang Liu, Wenyuan Liu, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 943-962
Open Access | Times Cited: 12

Process optimization of vanillin production by conversion of ferulic acid by Bacillus megaterium
Jingyu Gou, Yuxi Guo, Huan Liu, et al.
Journal of the Science of Food and Agriculture (2022) Vol. 102, Iss. 13, pp. 6047-6061
Closed Access | Times Cited: 11

DPHB, a diarylheptane from Alpinia officinarum Hance, ameliorates insulin resistance: A network pharmacology and in vitro study
Xiangyi Li, Huan Wen, Yuxin Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11

Immune-inflammatory modulation by natural products derived from edible and medicinal herbs used in Chinese classical prescriptions
Qianming Kang, Luying He, Yang Zhang, et al.
Phytomedicine (2024) Vol. 130, pp. 155684-155684
Closed Access | Times Cited: 2

Kai-Xin-San Protects Depression Mice Against CORT-Induced Neuronal Injury by Inhibiting Microglia Activation and Oxidative Stress
Guiqin Bai, Shangwen Jing, Huimin Cao, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 8

Herbal medicines in Alzheimer’s disease and the involvement of gut microbiota
Mingli Liu, Tuming Li, Huazheng Liang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

Effects and Components of Herb Pair Huanglian-Banxia on Diabetic Gastroparesis by Network Pharmacology
Guoqiang Liang, Lurong Zhang, Guorong Jiang, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-14
Open Access | Times Cited: 10

Network pharmacology integrated with experimental validation revealed the mechanism of Fengshi Gutong Capsule in the treatment of osteoarthritis
Yanqiu Sun, Jian Liu, Jue Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117261-117261
Open Access | Times Cited: 3

Network pharmacology analysis reveals neuroprotective effects of the Qin-Zhi-Zhu-Dan Formula in Alzheimer’s disease
Wenxiu Xu, Beida Ren, Zehan Zhang, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 5

Comparative pharmacokinetics of Ding‐Zhi‐Xiao‐Wan preparation and its single herbs in rats by using a putative multiple‐reaction monitoring UPLC‐MS/MS method
Yufei Sun, Yang He, Shuxin Liu, et al.
Phytochemical Analysis (2020) Vol. 32, Iss. 3, pp. 362-374
Closed Access | Times Cited: 6

Page 1 - Next Page

Scroll to top